In the mass tort realm, 2018 proved to be a year of high-volume verdicts and settlements coupled wit...
Blog
On November 16, 2017, a Texas federal jury awarded six individual plaintiffs a combined $247 million...
Counsel Financial was pleased to host a panel discussion—Emerging Mass Torts: Latest News from the E...
In 1985, Stanley Saltzman and Louis Marlin formed Marlin & Saltzman LLP. Beginning as a defense ...
HB Litigation Conferences Law firm funding company Counsel Financial announced today that it will co...
In 2007, Greg Coleman launched Greg Coleman Law PC, a plaintiffs’ class action, mass tort and person...
Among the hundreds of pending multidistrict litigations across the country, some stand out for the l...
Prominent defective drug and device attorney talks about the skillset, fortitude and passion require...
Ex-prosecutor and leader of rapidly expanding plaintiffs’ mass tort firm talks on overcoming fear, t...
Long-time shareholder of preeminent Georgia firm provides insight on how to pursue and build a plain...
On May 24, 2016, Johnson & Johnson (J&J) requested Judge Ed Kinkeade of the Northern Distric...
A recent ruling on the First Amendment rights of drug companies may be a stimulus for future mass to...
On Thursday, May 28, 2015, a Delaware State Court jury held that Boston Scientific Corporation must ...
Kelly Anthony, Esq., Assistant General Counsel Takeda Pharmaceuticals Company Limited, together with...
Counsel Financial recently returned from the Mass Torts Made Perfect (MTMP) Spring Seminar in Las Ve...